update

TG Therapeutics Inc

trading

Unbelievable how negative this stock trades against bio stocks with not much going on besides mediocre trials.

Big Loser Alert: Trading today&#39;s -7.2% move in TG THERAPEUTICS $TGTX https://wp.me/p5bLGB-iva5

↳ Why are you paying to be in a Trading Room?

action

$TGTX stock action negative this whole week.

$TGTX we&#39;re missing something here, the price action is a bit worrisome.

This price action is pathetic after holding this bag for years.

life

manipulation

It&#39;s eye opening to see the blatant manipulation.

$TGTX no real sellers here, all fake manipulation

Screw off $GS   hope they get crushed from the sec for stock manipulation  I can’t stand these fools.

Practically the only thing red today… lame 😒

$TGTX $19.00 in the red 😎 this thing sends chills down my arms.

Super excited for tomorrow&#39;s ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!

They&#39;re FDA approved, have the best in class treatment, and is more affordable than the others.

$JAZZ $TGTX FDA APPROVED ON 12/28/22 . BUY/HOLD/ACCUMULATE

$KALA  up 46%, rallies 3rd day in a row following FDA acceptance of IND application of KPI-012 &amp;  
$TGTX is up 13% continued momentum following MS drug approvals.

Our  best  in  class  drug  is  FDA  APPROVED.

$TGTX $KALA $HOTH $NUWE 

TGTX on fire 🔥 and solid from fundamentals perspective after yesterday FDA approval of Multiple Sclerosis Billion dollar drug revenue potential.

Great FDA approval news in a growing MS market with a need.

$TGTX , absolutely amazing….Scumbag’s Bank of America analyst rated TG today as underperform $6….total joke….I guess the analyst is waiting for FDA approval…LOL ….stick to loans and mortgages….very bullish TG community Longs….

$TGTX FDA approval for Billion dollar MS drug — great things in store 2023

$DRMA just officially dropped offering, makes me feel company has something good up it’s sleeve.

.. FDA APPROVED ON 12/28/22 BEST IN CLASS .

hold

$TGTX Worthwhile hold and in time will be quite profitable.

$TGTX Please hold your shares or buy more on the dip You will be very pleased with the outcome

$TGTX good day Bulls, just hold for the gold!! !

This will be huge, and the sp for BO will be massive in 2yrs if they hold out. 100+

Buy, Accumulate, Hold…it’s common sense.

$TGTX &gt; STRONG BUY = BUY/HOLD/ACCUMULATE.

market

Chartwise,  i  would think  this  is   pretty bullish;  given  crap  market. Thoughts?

$TGTX This is the rocky Biden market u all wanted.

Remember that we are ultimately at the beginning of commercialization and quite possible the safest spot to be with the current facts on our superior Briumvi treatment and best pricing for market share penetration.

$TGTX market is doing good, we doing good

$TGTX Looking strong today despite the market.

TG&#39;s Briumvi is positioned to take market share because of these advantages, including how much better it is than all other competitors.

$TGTX  
I found this on NewsBreak: The stock market is on the verge of a rare bullish trifecta that suggests big upside ahead  
https://share.newsbreak.com/2tuqqt3a

I have done plenty of research lately on the market TAM and this looks primed to move quickly once it gets rolling.

$TGTX Up 23% from the lows of pre market 3 trading days ago.

Jasper Therapeutics Inc

bear

$JSPR the bull that sold at 2.23 and turn bear 🐻

pump-and-dump

$JSPR   Haha, another batch of stupid longs just got trapped after the pump and dump, $2.85 to $1.85, down -35% in a day.

$JSPR  Down -25% to $2.08 on this trash stock on the dump. lol

$JSPR 
Another dump as he’s pumping 
Fkin loser

$JSPR I call these discord pumps that violative

trap

joke

wall

$JSPR FDA approval here a few weeks ago, this baby isn’t going down,

positive PURSUIT outcome and FDA approval would open a multibillion-dollar commercial opportunity for Viveve.

$BJDX .41 great entry ahead of FDA news just like $JSPR +600% monster run!

gain

broke 2.50 resistance, consider locking in 59% gains from opening bell   Next 2.75 and 3

This figure makes room for additional gains of a hefty 264% over the coming year.

he already made his daily gains now he&#39;s gonna go enjoy his day. perfect

$JSPR We alerted early on #JSPR and saw a same-day MAX GAIN of 130%!

Beautiful run-up for the close of the year on $KALA , then $JSPR showed a classic run-up for a 350% gain today with $ATNF having a continuation play for a 200% plus gain over the new year!

afterhours

$LMFA ——- favorite going into next week💪Daily is primed weekly is breaking out and AH movement was insane!

Premarket Gainers: 
 
$JSPR 
+34% / 5.4 MIL VOL 
 
$GFAI 
+16.5% / 4.6 MIL VOL 
 
$ZVSA  
+70% / 3.3 MIL VOL 
 
$QBTS  
+15.5% / 2.8 MIL VOL

Gappers in premarket trading, 

$ZVSA $GROM $JSPR $APRN $ARVL 

Let’s finish the week strong! 📈✅

$HTGM 5.03$ right now and moving up in premarket.

Printed several new highs in AH and now just new high after new high. $MULN

start

$JSPR $LHDX dosent look good, u better start work here

$JSPR over 3.75 before ah starts hault up hault up hault up 🔥🔥🔥

SELLAS Life Sciences Group Inc

buying

$SLS  I wont be buying anymore shares until the CEO can show is company is worth at least 150m marketcap 
 
Look at the 3 year chart be warned the CEO is a scam artist and a liar

You are better off hoarding cash vs buying into a company where the staff sells free shares and does not deserve pay raises during a economic crisis/recession.

$SLS  No one should be buying in at these prices though.

$SLS SERIOUSLY STOP FUCKING RUNNING ALL THE BUYING OTC DARK POOL!!!

This MM is refusing to honor order flow, they are refusing to move the price higher when buying comes in, they are dictating price direction and that&#39;s not their fucking job.

HOW THE FUCK DID THEY JUST FILL 24k BUYING VOLUME AND NOT A SINGLE $.01 MOVE!!!!

but buying inflow and a 5K buy order and yet POS MM will not let it fucking go!! !

application

Gfh009 is a joke and will ruin this stock until 3d meds sees fda approval for aml gps.

16/16 
In all 3 Options GPs gets FDA approval due to QOL, venclexta, onureg, oralAz - all Cr1 salvage agents are highly toxic.

This concerns me, we get the dreaded not statistically relevant ruling from the FDA.

- OUTRIGHT LIE saying THEN 52 weeks - PURE BS 
- OUTRIGHT LIE saying THEN patients need to Die 
Co is now on RECord Reiterating 80 Events, patient deaths in Q1Q2 
That is the fda green light moment.

announcement

You fucked up and shorted NCI non dilutive funding announcement and patients living longer news.

$SLS they supposedly hired a lawyer fill time and this was never announced .

The shorts feeling the pain on their announcement.

$SLS For those predicting some big announcement from Sellas on the 14th at the Regal symposium, you are going to be terribly disappointed.

investor

What a freaking smack in the face to investors.

Angelos has intentionally screwed the long term investor.

$SLS I find it arrogant that SLS would even investors were concerned about their SIVB exposure.

but after doing an offering and the way the market is, the company should be giving some communication,  otherwise you are showing you really don&#39;t care about long term  investors,  personally  I&#39;m not impressed with the way it&#39;s been handled.

$SLS This is a JOKE and the JOKE is on the real investors ☹️

$SLS SLS investors have two problems now.

If you’re an experienced investor and you buy this scam, you deserve to lose you your investment.

$SLS No one should buy  in to this unless you are new investor.

They need to communicate and support their investors and shareholders.

Scary that I bought 2 years ago 9000 shares $6.50 average price to see this today just seems like he doesn’t care at all for investors why would he?

$sls $ocea   pre-market updates 🚀  ideal.live-trading-alerts.tech 
22

$SLS interesting and positive update from Sellas. 1.

$SLS NCT update, nice…
They target 140 patients in 110 investigational sites.

$GNS is still Going - Now Up 1,500% in a Week and Likely to add another 1,000% $SLS is NEXT Grab a Few while they are CHEAP as F. Jan 31 P3 Asset Update.

Either-way very much looking forward to this update!! !

- Last Update 30mg Dose &gt;50% complete Response and or Stable Disease - Efficacy Increases Proportionally to dosage.

We also had a very good REGAL update with the expansion with China and 13M in 1st Q (which is new).

At the last update, Gps Opdivo mOs at 10.4 months- no safety issues.

$SLS Tutes will load moving forward with all the updates.

A 300% gain in less than a month - and this time sis has plenty of cash in the tank to keep on running to the FDA green light.

$SLS my vote is get GPS green lighted for FDA approval and ramp this company up for M&amp;A.  GPS and GFH009 are high potential assets

Really is a great set up here - Get the FDA Green light and collect $50M plus another $25M warrants at $5.40.

$SLS In addition to GPs FDA approval for AML secondary Remission patients - Gps + Keytruda/Checkpoint Inhibition is also best in class for Ovarian cancer patients.

- Gps FDA Approval only a matter of time and is worth $8B in Market Value to Big Pharma  
- SlS current market cap of $.067B 
Best Short term investment any of us will find for a long. time.

Great Set Up here - $25M total incoming in Q1/2, Then another $50M when Gps gets the FDA green light - usually that is when small bios need to raise cash, and shorts can cover -- Ange Has them Over a barrel.

I think the share price will be climbing all along the approach to the FDA green light.

2,500% to 5,000% Upside in this ahead of the Fda Green light for Gps, as the first immunotherapy to treat 20,000 AML remission patients.

His 25-year experience, with global drug/biologics approvals and Breakthrough Therapy Designation with FDA, will be of immense value to our organization, especially as 2023 will be a pivotal year for our Company - welcome Andrew!

patient

It reported positive outcomes in pleural mesothelioma patients, including:
Improved survival: Study patients lived around 11 months.

* Best Available Therapy offers 6-8 months of Overall Survival  
* All pooled Regal patients, BAT and Gps combined, is 16 months.

* Best Available Therapy offers 6-8 months of Overall Survival 
* All pooled Regal patients, BAT and Gps combined, is 16 months.

Now phase 3 trial is showing similar results to date where patients are living longer after Galinpepimut-S up to 1.5 year longer is a breakthrough for AML patients.

- Best available treatment 6-8 months of os.

- Cured GPS patients, continue to elongate the OS curve in Gps favor every day that goes by.

news

$SLS With news on its way, the confidence built in the science, fear factor is gone.

$SLS No breaking news here regarding Sellas, and its well above my understanding,

$SLS good news, at the current rate and the ridiculous prices, in about a month you can buy this company for free.

My guess is that they generated ~3m revenue through the EAP, which would be really great news.

This is a rare opportunity that you know the news is grossly good(it convinced in investor(s)) and still have the chance to load and make 50 to 100% in .month or so.

plenty of upside if there is positive news.

$SLS they picked a great day for this news. lol

So much for this offering being good news.

Positive trial data/results supported with bullish news and sentiment! 4.

trial

PROC data are excellent compared to any combo trials.

But yesterdays paper also has me considering, if there isn&#39;t a deal with $mrk or $BMY or some other CPI BP  
--- That data is Best In Class - best in clinic, best in trial too.

The nation’s best means the O&#39;Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.

Gps is doing what it has done in every single trial and its the reason Patients are living 3 fold longer than patients on best available treatments.

Treatment with GFH009 resulted in 90 to 100 percent cancer inhibition at dose levels equivalent to those already demonstrated to be safe in patients in the ongoing Phase 1 trial with no viable cancer cells at the highest dose levels.

Top Stocks matching your search for "update fda"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

JSPR

Jasper Therapeutics Inc

3.78%

$1.85 - $1.92

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb, 24, 2023

Feb, 5, 2023

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

JSPR

Jasper Therapeutics Inc

3.78%

$1.85 - $1.92

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb, 24, 2023

Feb, 5, 2023

Feb, 1, 2023

Jan, 24, 2023

Jan, 19, 2023

Jan, 18, 2023

Dec, 15, 2022

Dec, 15, 2022

Dec, 8, 2022